Loading…
Loading…
CBNT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CBNT and 80,000+ other tickers.
See exactly how CBNT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CBNT and 80,000+ other tickers.
C-Bond Systems, Inc., a nanotechnology enterprise founded in 2013 and based in Houston, Texas, concentrates on the ownership, development, production, and sale of its proprietary C-Bond technology across the United States. The company's innovative product line, rooted in C-Bond technology, includes: C-Bond NanoShield: A patented nanotechnology system designed to bolster windshield safety and performance through glass strengthening and the application of hydrophobic properties. C-Bond Secure: This patented, non-toxic, water-based nanotechnology solution enhances the durability of architectural…
The companies have patent-pending technology for more precise dosing for nutraceuticals and pharmaceuticals using its SureDose™ process Don Swanson, principal of Gummy USA, SureDose, and Creative Manufacturing will become Chairman of the combined entity POMPANO BEACH, FL / ACCESS Newswire / February 11, 2025 / C-Bond Systems (the "Company" or "C-Bond") (OTC PINK:CBNT) today announced that it has entered into a term sheet to acquire the assets of Gummy USA, LLC, SureDose, LLC, and Creative Manufacturing, LLC, players in the $25 billion nutraceutical gummy industry with patent-pending technology designed to ensure more precise dosing for nutraceutical and pharmaceutical gummies through its proprietary SureDose process. Gummy USA, SureDose, and Creative Manufacturing are owned and operated by Don Swanson, a recognized innovator in nutraceutical, OTC, and pharmaceutical gummy manufacturing and dosing technology.
This transaction eliminates the Company's secured debt and redeems all its Series C Preferred Stock while positioning the Company for new growth opportunities SAN ANTONIO, TX and POMPANO BEACH, FL / ACCESS Newswire / February 4, 2025 / C-Bond Systems (the "Company" or "C-Bond") (OTC PINK:CBNT) today announced that it has completed a debt forgiveness, equity redemption, and strict foreclosure transaction with its secured creditors valued at more than $3 million. Per the terms of the agreement, over $2 million of senior debt was forgiven and approximately $1 million of equity, which included Series C Preferred shares, common shares, and warrants, was redeemed and returned to the Company.
The installation includes a combination of C-Bond's Ballistic-Resistant System, C-Bond Secure, and solar film on multiple floors of the university The installation includes a combination of C-Bond's Ballistic-Resistant System, C-Bond Secure, and solar film on multiple floors of the university
Patriot Glass Solutions to install C-Bond Secure and Solar Film at Company's Corporate Offices Patriot Glass Solutions to install C-Bond Secure and Solar Film at Company's Corporate Offices
SAN ANTONIO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, today announced that SeaWorld® has selected C-Bond's Patriot Glass Solutions subsidiary to install protective film on sea life tanks at the theme park. This is the second job that Patriot Glass Solutions was awarded at the theme park.